Spilovska, K.; Korabecny, J.; Kral, J.; Horova, A.; Musilek, K.; Soukup, O.; Drtinova, L.; Gazova, Z.; Siposova, K.; Kuca, K.
7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer’s Disease Treatment — Synthesis, Biological Evaluation and Molecular Modeling Studies. Molecules 2013, 18, 2397-2418.
https://doi.org/10.3390/molecules18022397
AMA Style
Spilovska K, Korabecny J, Kral J, Horova A, Musilek K, Soukup O, Drtinova L, Gazova Z, Siposova K, Kuca K.
7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer’s Disease Treatment — Synthesis, Biological Evaluation and Molecular Modeling Studies. Molecules. 2013; 18(2):2397-2418.
https://doi.org/10.3390/molecules18022397
Chicago/Turabian Style
Spilovska, Katarina, Jan Korabecny, Jan Kral, Anna Horova, Kamil Musilek, Ondrej Soukup, Lucie Drtinova, Zuzana Gazova, Katarina Siposova, and Kamil Kuca.
2013. "7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer’s Disease Treatment — Synthesis, Biological Evaluation and Molecular Modeling Studies" Molecules 18, no. 2: 2397-2418.
https://doi.org/10.3390/molecules18022397
APA Style
Spilovska, K., Korabecny, J., Kral, J., Horova, A., Musilek, K., Soukup, O., Drtinova, L., Gazova, Z., Siposova, K., & Kuca, K.
(2013). 7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer’s Disease Treatment — Synthesis, Biological Evaluation and Molecular Modeling Studies. Molecules, 18(2), 2397-2418.
https://doi.org/10.3390/molecules18022397
